Kura Oncology, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $23.2M | $242.0M | $26.1M |
| FY2020 | $36.3M | $647.2M | $325.5M |
| FY2021 | $27.4M | $534.1M | $90.7M |
| FY2022 | $36.0M | $456.3M | $51.8M |
| FY2023 | $51.7M | $448.9M | $37.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $23.2M | $242.0M | $26.1M |
| FY2020 | $36.3M | $647.2M | $325.5M |
| FY2021 | $27.4M | $534.1M | $90.7M |
| FY2022 | $36.0M | $456.3M | $51.8M |
| FY2023 | $51.7M | $448.9M | $37.3M |